Redpin Therapeutics

Pharmaceutical Manufacturing Currently Intractable Diseases of the Nervous System. Our Approach Integrates Powerful Principles from Synthetic Biology 6 employees

Employees: 6

redpinrx.com LinkedIn Crunchbase

Redpin Therapeutics Overview

Headquarters: Currently Intractable Diseases of the Nervous System. Our Approach Integrates Powerful Principles from Synthetic Biology
Phone Number: Available in AeroLeads
Website: redpinrx.com
Industry: Pharmaceutical Manufacturing
Employees: 6
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Parsippany

About Redpin Therapeutics

Redpin Therapeutics is a privately-held, preclinical stage gene therapy company based in New York City. We are developing a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Our approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy. Our science is based on the groundbreaking discovery and development of an ultrapotent ion channel-based chemogenetics platform that enables targeted cell activation or inhibition controlled by low doses of the anti-smoking drug varenicline (CHANTIX®).